Reply:Atherosclerosis and vascular cognitive impairment neuropathological guideline by Skrobot, Olivia A et al.
                          Skrobot, O. A., Attems, J., Esiri, M., Hortobágyi, T., Ironside, J. W., Kalaria,
R. N., ... Love, S. (2016). Reply: Atherosclerosis and vascular cognitive
impairment neuropathological guideline. Brain, 140(2), [e13].
https://doi.org/10.1093/brain/aww305
Peer reviewed version
Link to published version (if available):
10.1093/brain/aww305
Link to publication record in Explore Bristol Research
PDF-document
This is the author accepted manuscript (AAM). The final published version (version of record) is available online
via OUP at https://academic.oup.com/brain/article-lookup/doi/10.1093/brain/aww305. Please refer to any
applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
Reply: Atherosclerosis and Vascular Cognitive Impairment Neuropathological 
Guidelines (VCING) 
 
O. A. Skrobot1, J. Attems2, M. Esiri3, T. Hortobágyi4, J. W. Ironside5, R. N. Kalaria2, A. 
King6, G. A. Lammie7, D. Mann8, J. Neal9, Y. Ben-Shlomo10, P. G. Kehoe1, S. Love1 
 
1Dementia Research Group, School of Clinical Sciences, Faculty of Health Sciences, 
University of Bristol, Level 1, Learning & Research, Southmead Hospital, Bristol, BS10 
5NB, UK; 2Institute of Neuroscience and Newcastle Institute for Ageing, Newcastle 
University, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL, UK; 3 
Nuffield Department of Clinical Neurosciences, Oxford University, Oxford, OX3 9DU, 
UK; 4Department of Neuropathology, Institute of Pathology, Faculty of Medicine, 
University of Debrecen, Nagyerdei krt. 98, Debrecen, 4032, Hungary & Department 
of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and 
Neuroscience, King’s College London, De Crespigny Park, London, SE5 8AF, UK; 
5Centre for Clinical Brain Sciences, University of Edinburgh, Western General 
Hospital, Crewe Road, Edinburgh, Midlothian, EH4 2XU UK; 6Department of Clinical 
Neuropathology, First floor, Academic Neuroscience Building, King's College Hospital, 
Denmark Hill, London, SE5 9RS, UK;  7Institute of Cancer & Genetics, Cardiff 
University School of Medicine, Institute of Medical Genetics Building, Heath Park, 
Cardiff, CF14 4XN, UK; 8Institute of Brain, Behaviour and Mental Health, Clinical and 
Cognitive Neuroscience Research group, University of Manchester, A304 Clinical 
Sciences Building, Salford Royal Hospital, Stott Lane, Salford M6 8HD; 9 Institute of 
Infection & Immunity, Cardiff University School of Medicine, Henry Wellcome 
Building, Heath Park, Cardiff CF14 4N, UK; 10School of Social and Community 
Medicine, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. 
 
Correspondence to: Seth Love  
 
School of Clinical Sciences, University of Bristol, Learning & Research level 2, 
Southmead Hospital, Bristol BS10 5NB, UK 
E-mail: seth.love@bristol.ac.uk 
 
 
Sir, 
Our aim in developing the Vascular Cognitive Impairment Neuropathological 
Guidelines (VCING) was to establish criteria that we could show to be highly 
reproducible between neuropathologists in different centres, for post-mortem 
assessment of the likelihood that cognitive impairment was attributable to 
cerebrovascular pathology. To ensure reproducibility, we performed blinded post-
mortem assessment of sections of brain tissue that were circulated to nine 
neuropathologists in centres across the UK. The advantage of this approach was that 
it enabled us to develop a protocol that can easily and reliably be applied in centres 
other than those participating in the VCING project. However, as noted by 
Oveisgharan and Hachinski (Oveisgharan and Hachinski, 2016), our approach did 
impose certain practical constraints on the scope and scale of the study. In 
particular, it restricted our assessment to variables that could be evaluated by 
examination of histological sections, and limited the number of cases that it was 
practicable to assess (as each case required the assessment of 151 separate 
variables by 9 neuropathologists). 
We agree that other studies have found moderate to severe atherosclerosis of 
the carotid arteries or circle of Willis to be associated not only with microinfarcts, 
lacunar infarcts and larger cerebral infarcts (Arvanitakis et al., 2016b; Dolan et al., 
2010; Reed et al., 1994; Reed et al., 1988) but also dementia (Arvanitakis et al., 
2016a; Dolan et al., 2010). Although atherosclerosis of the basal arteries was, for the 
stated reasons, not one of the variables included in our modelling of the risk of 
cognitive impairment, we have now reanalysed the data after incorporating 
information on circle of Willis atherosclerosis (recorded by the examining 
neuropathologist for all but 3 of the cases) in our predictive models. In our cohort, 
we find moderate/severe atherosclerosis to be a significant predictor of MMSE < 27 
(p = 0.02), even in the presence of the other three most strongly predictive 
covariates (moderate/severe occipital leptomeningeal cerebral amyloid angiopathy, 
moderate/severe arteriolosclerosis in occipital white matter, and at least one large 
infarct), but not to predict a clinical diagnosis of dementia, MMSE < 24, or cognitive 
impairment, the last of these being the primary outcome measure in our study. 
There is evidence that atherosclerosis of the circle of Willis may be a risk factor 
for Alzheimer's disease (Beach et al., 2007; Honig et al., 2005; Roher et al., 2003; 
Yarchoan et al., 2012) and, as noted above, it is associated with cerebral infarcts that 
are themselves a risk factor for vascular cognitive impairment. Dolan et al. (2010) 
found that intracranial atherosclerosis was associated with an increased risk of 
dementia that was independent of Alzheimer's disease pathology or cerebral infarcts 
in the Baltimore Longitudinal Study of Aging cohort, but it remains to be established 
whether circle of Willis atherosclerosis is truly an independent determinant of 
vascular cognitive impairment. We suggest that this merits further research, and 
would encourage studies to assess the reproducibility of the VCING model in much 
larger cohorts, preferably with standardised prospective collection of cognitive data. 
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